中遠海控(01919.HK)子公司擬5927.6萬美元轉讓中遠海運港口(阿布扎比)33.335%股份
格隆匯11月26日丨中遠海控(01919.HK)公告,公司間接控股子公司中遠海運港口有限公司(“中遠海運港口”)以5927.6萬美元的價格向青島港國際發展(香港)有限公司(“青島港香港”)轉讓其全資子公司中遠海運港口(阿布扎比)有限公司(“標的公司”)33.335%股份,從而間接轉讓標的公司直接及通過信託持股方式合計持有90%股份的CSP Abu Dhabi Terminal L.L.C.(“阿布扎比合資公司”)的30.0015%股份。
中遠海運港口一直以來致力於發展碼頭業務,阿布扎比合資公司是其在中東地區的第一個控股碼頭,體現了其積極打造全球碼頭網絡的戰略佈局。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.